glp-1 chronic kidney disease Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic through dampening the receptor for advanced glycation end products–induced inflammation GLP-1 Receptor Agonists and Diabetic
Description
Gastrointestinal adverse effects of GLP-1 agonistsincluding nausea, vomiting, and dehydrationcould be exacerbated by alcohol use and may complicate medication adherence
Doctors often recommend starting with a low dose and titrating up to find the amount that supports the persons goals while minimizing side effects, like gastrointestinal distress, fatigue, and an increased heart rate
Very low-calorie diets should only be followed under medical supervision
PlexusDx evaluates your complete health picture during your consultation to determine candidacy
2023;382:1213 (FDA) USFaDA: FDA approves new drug treatment for chronic weight management, first since 2014
Generic drugs often are a lower-cost option to brand-name drugs
